Hemoptysis and unilateral intra-alveolar hemorrhage complicating intravenous thrombolysis for myocardial infarction.
This report deals with a patient who developed hemoptysis due to unilateral intra-alveolar hemorrhage after receiving tissue-type plasminogen activator (TPA) for acute myocardial infarction; the patient had sustained an ipsilateral lung injury 2 years earlier.
Hammoudeh
A J
AJ
Department of Cardiology, Saint Michael's Medical Center, Newark, New Jersey 07102, USA.
Haft
J I
JI
Eichman
G T
GT
D000368:Aged; D006469:Hemoptysis / Q000209:etiology*; D006470:Hemorrhage / Q000209:etiology*; D006801:Humans; D008171:Lung Diseases / Q000209:etiology*; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy*; D010960:Plasminogen Activators / Q000627:therapeutic use*; D015912:Thrombolytic Therapy / Q000009:adverse effects*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator